Investigate subjective effects and nicotine pharmacokinetics of mentholated smokeless tobacco products in current users
Ended Awarded Last action
- Contract number
- HHSF22301003T
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,835,595
Award facts
- Contract value 100% obligated
- $1,835,595.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$8,711 | |
| Other Administrative Action | $21,575 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,822,731 |
About this award
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The contract has a potential value of $1,835,595.00 and is for a study to investigate the subjective effects and nicotine pharmacokinetics of mentholated smokeless tobacco products in current users. The contract is part of a larger Tobacco Products Pharmacology Study indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Lovelace Biomedical Research Institute has previously served as a prime contractor for preclinical research services, including animal toxicology and efficacy studies, as well as a subcontractor on clinical research studies, for various HHS agencies. The institute also holds other indefinite delivery contracts and blanket purchase agreements with HHS, DoD, and other agencies to provide flexible contracting mechanisms for preclinical research services.
Quick answers
Who was awarded contract HHSF22301003T?
HHSF22301003T was awarded to Lovelace Biomedical Research Institute by Food and Drug Administration (Department of Health and Human Services) on September 20, 2017.
How much is contract HHSF22301003T worth?
The government has obligated $1,835,595 on HHSF22301003T.
Is contract HHSF22301003T an order under another contract?
Yes. HHSF22301003T is a delivery order under HHSF223201310033I, an indefinite delivery contract, on Tobacco Products Pharmacology Study.
Was contract HHSF22301003T competed?
The extent of competition for HHSF22301003T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award